Methanolic Fenugreek Seed Extract Induces p53-Dependent Mitotic Catastrophe in Breast Cancer Cells, Leading to Apoptosis

References

• Gray A, Dang BN, Moore TB, et al. A review of nutrition and dietary interventions in oncology. SAGE Open Med. 2020;8:2050312120926877. doi:10.1177/2050312120926877
   Web of Science ®Google Scholar
• Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134(12 Suppl):3479s–3485s. doi:10.1093/jn/134.12.3479S
   PubMed Web of Science ®Google Scholar
• Kaefer CM, Milner JA. Herbs and spices in cancer prevention and treatment. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2011:Chapter 17. Available from: www.ncbi.nlm.nih.gov/books/NBK92774/.
   Google Scholar
• Birt DF, Pelling JC, Nair S, et al. Diet intervention for modifying cancer risk. Prog Clin Biol Res. 1996;395:223–234.
   PubMedGoogle Scholar
• Goodwin JS, Brodwick M. Diet, aging, and cancer. Clin Geriatr Med. 1995;11(4):577–589. doi:10.1016/S0749-0690(18)30258-1
   PubMed Web of Science ®Google Scholar
• Pal D, Banerjee S, Ghosh AK. Dietary-induced cancer prevention: an expanding research arena of emerging diet related to healthcare system. J Adv Pharm Technol Res. 2012;3(1):16–24. doi:10.4103/2231-4040.93561
   PubMedGoogle Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770–803. doi:10.1021/acs.jnatprod.9b01285
   PubMed Web of Science ®Google Scholar
• El Bairi K, Ouzir M, Agnieszka N, et al. Anticancer potential of Trigonella foenum graecum: cellular and molecular targets. Biomed Pharmacother. 2017;90:479–491. doi:10.1016/j.biopha.2017.03.071
   PubMed Web of Science ®Google Scholar
• Nagulapalli Venkata KC, et al. A small plant with big benefits: fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Mol Nutr Food Res. 2017;61(6).
   PubMed Web of Science ®Google Scholar
• Yadav UCS, Baquer NZ. Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm Biol. 2014;52(2):243–254. doi:10.3109/13880209.2013.826247
   PubMed Web of Science ®Google Scholar
• Parvizpur A, Ahmadiani A, Kamalinejad M. Probable role of spinal purinoceptors in the analgesic effect of Trigonella foenum (TFG) leaves extract. J Ethnopharmacol. 2006;104(1–2):108–112. doi:10.1016/j.jep.2005.08.057
   PubMed Web of Science ®Google Scholar
• Kaviarasan S, Sundarapandiyan R, Anuradha CV. Protective action of fenugreek (Trigonella foenum graecum) seed polyphenols against alcohol-induced protein and lipid damage in rat liver. Cell Biol Toxicol. 2008;24(5):391–400. doi:10.1007/s10565-007-9050-x
   PubMed Web of Science ®Google Scholar
• Kumar P, Bhandari U. Protective effect of Trigonella foenum-graecum Linn. on monosodium glutamate-induced dyslipidemia and oxidative stress in rats. Indian J Pharmacol. 2013;45(2):136–140. doi:10.4103/0253-7613.108288
   PubMed Web of Science ®Google Scholar
• Zhang H, Xu J, Wang M, et al. Steroidal saponins and sapogenins from fenugreek and their inhibitory activity against α-glucosidase. Steroids. 2020;161:108690. doi:10.1016/j.steroids.2020.108690
   PubMed Web of Science ®Google Scholar
• Petit PR, Sauvaire YD, Hillaire-Buys DM, et al. Steroid saponins from fenugreek seeds: extraction, purification, and pharmacological investigation on feeding behavior and plasma cholesterol. Steroids. 1995;60(10):674–680. doi:10.1016/0039-128X(95)00090-D
   PubMed Web of Science ®Google Scholar
• Stark A, Madar Z. The effect of an ethanol extract derived from fenugreek (Trigonella foenum-graecum) on bile acid absorption and cholesterol levels in rats. Br J Nutr. 1993;69(1):277–287. doi:10.1079/BJN19930029
   PubMed Web of Science ®Google Scholar
• Yoshikawa M, Murakami T, Komatsu H, et al. Medicinal foodstuffs. IV. Fenugreek seed. (1): structures of trigoneosides Ia, Ib, IIa, IIb, IIIa, and IIIb, new furostanol saponins from the seeds of Indian Trigonella foenum-graecum L. Chem Pharm Bull (Tokyo). 1997;45(1):81–87.
   PubMed Web of Science ®Google Scholar
• Sauvaire Y, Ribes G, Baccou J-C, et al. Implication of steroid saponins and sapogenins in the hypocholesterolemic effect of fenugreek. Lipids. 1991;26(3):191–197. doi:10.1007/BF02543970
   PubMed Web of Science ®Google Scholar
• Moorthy R, Prabhu KM, Murthy PS. Mechanism of anti-diabetic action, efficacy and safety profile of GII purified from fenugreek (Trigonella foenum-graceum Linn.) seeds in diabetic animals. Indian J Exp Biol. 2010;48(11):1119–1122.
   PubMed Web of Science ®Google Scholar
• Naicker N, Nagiah S, Phulukdaree A, et al. Trigonella foenum-graecum Seed Extract, 4-hydroxyisoleucine, and metformin stimulate proximal insulin signaling and increase expression of glycogenic enzymes and GLUT2 in HepG2 Cells. Metab Syndr Relat Disord. 2016;14(2):114–120. doi:10.1089/met.2015.0081
   PubMed Web of Science ®Google Scholar
• Vijayakumar MV, Singh S, Chhipa RR, et al. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. Br J Pharmacol. 2005;146(1):41–48. doi:10.1038/sj.bjp.0706312
   PubMed Web of Science ®Google Scholar
• Xue WL, Li XS, Zhang J, et al. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr. 2007;16(Suppl 1):422–426.
   PubMedGoogle Scholar
• Belguith-Hadriche O, Bouaziz M, Jamoussi K, et al. Comparative study on hypocholesterolemic and antioxidant activities of various extracts of fenugreek seeds. Food Chem. 2013;138(2–3):1448–1453. doi:10.1016/j.foodchem.2012.11.003
   PubMed Web of Science ®Google Scholar
• Hozzein WN, Saleh AM, Habeeb TH, et al. CO2 treatment improves the hypocholesterolemic and antioxidant properties of fenugreek seeds. Food Chem. 2020;308:125661. doi:10.1016/j.foodchem.2019.125661
   PubMed Web of Science ®Google Scholar
• Hegazy MG, Emam MA. Ethanolic extract of Trigonella Foenum Graecum attenuates cisplatin-induced nephro- and hepatotoxicities in rats. Cell Mol Biol (Noisy-Le-Grand). 2015;61(7):81–87.
   PubMed Web of Science ®Google Scholar
• Das S, Dey KK, Dey G, et al. Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS One. 2012;7(10):e46641. doi:10.1371/journal.pone.0046641
   PubMed Web of Science ®Google Scholar
• Jagadeesan J, Nandakumar N, Rengarajan T, et al. Diosgenin, a steroidal saponin, exhibits anticancer activity by attenuating lipid peroxidation via enhancing antioxidant defense system during NMU-induced breast carcinoma. J Environ Pathol Toxicol Oncol. 2012;31(2):121–129. doi:10.1615/JEnvironPatholToxicolOncol.v31.i2.40
   PubMed Web of Science ®Google Scholar
• Raju J, Patlolla JMR, Swamy MV, et al. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomarkers Prev. 2004;13(8):1392–1398.
   PubMed Web of Science ®Google Scholar
• Amin A, Alkaabi A, Alfalasi S, et al. Chemopreventive activities of (Fenugreek) against breast cancer. Cell Biol Int. 2005;29(8):687–694. doi:10.1016/j.cellbi.2005.04.004
   PubMed Web of Science ®Google Scholar
• Alsemari A, Alkhodairy F, Aldakan A, et al. The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum. BMC Complement Altern Med. 2014;14(1):114. doi:10.1186/1472-6882-14-114
   PubMedGoogle Scholar
• Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82(13):1107–1112. doi:10.1093/jnci/82.13.1107
   PubMed Web of Science ®Google Scholar
• Singleton VL, Orthofer R, Lamuela-Raventós RM. [14] Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. In: Packer L, editor. Methods in Enzymology. Academic Press; 1999:152–178.
   Google Scholar
• Quettier-Deleu C, Gressier B, Vasseur J, et al. Phenolic compounds and antioxidant activities of buckwheat (Fagopyrum esculentum Moench) hulls and flour. J Ethnopharmacol. 2000;72(1–2):35–42. doi:10.1016/S0378-8741(00)00196-3
   PubMed Web of Science ®Google Scholar
• Sharma OP, Bhat TK. DPPH antioxidant assay revisited. Food Chem. 2009;113(4):1202–1205. doi:10.1016/j.foodchem.2008.08.008
   Web of Science ®Google Scholar
• Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2(2):329–333. doi:10.1038/nprot.2007.30
   PubMed Web of Science ®Google Scholar
• OECD. Test No. 420: Acute Oral Toxicity - Fixed Dose Procedure; 2002.
   Google Scholar
• Shabbeer S, Sobolewski M, Anchoori RK, et al. Fenugreek: a naturally occurring edible spice as an anticancer agent. Cancer Biol Ther. 2009;8(3):272–278. doi:10.4161/cbt.8.3.7443
   PubMed Web of Science ®Google Scholar
• Rahmati-Yamchi M, Ghareghomi S, Haddadchi G, et al. Fenugreek extract diosgenin and pure diosgenin inhibit the hTERT gene expression in A549 lung cancer cell line. Mol Biol Rep. 2014;41(9):6247–6252. doi:10.1007/s11033-014-3505-y
   PubMed Web of Science ®Google Scholar
• Alshatwi AA, Shafi G, Hasan TN, et al. Fenugreek induced apoptosis in breast cancer MCF-7 cells mediated independently by fas receptor change. Asian Pac J Cancer Prev. 2013;14(10):5783–5788. doi:10.7314/APJCP.2013.14.10.5783
   PubMedGoogle Scholar
• Khoja KK, Shaf G, Hasan TN, et al. Fenugreek, a naturally occurring edible spice, kills MCF-7 human breast cancer cells via an apoptotic pathway. Asian Pac J Cancer Prev. 2011;12(12):3299–3304.
   PubMedGoogle Scholar
• Khalil MIM, Ibrahim MM, El–Gaaly GA, et al. Trigonella foenum (Fenugreek) induced apoptosis in hepatocellular carcinoma cell line, HepG2, mediated by upregulation of p53 and proliferating cell nuclear antigen. Biomed Res Int. 2015;2015:914645. doi:10.1155/2015/914645
   PubMed Web of Science ®Google Scholar
• Chao HX, Poovey CE, Privette AA, et al. Orchestration of DNA damage checkpoint dynamics across the human cell cycle. Cell Syst. 2017;5(5):445–459.e5. doi:10.1016/j.cels.2017.09.015
   PubMed Web of Science ®Google Scholar
• Banin S, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 1998;281(5383):1674–1677. doi:10.1126/science.281.5383.1674
   PubMed Web of Science ®Google Scholar
• Canman CE, Lim DS, Cimprich KA, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 1998;281(5383):1677–1679. doi:10.1126/science.281.5383.1677
   PubMed Web of Science ®Google Scholar
• Redon C, Pilch D, Rogakou E, et al. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev. 2002;12(2):162–169. doi:10.1016/S0959-437X(02)00282-4
   PubMed Web of Science ®Google Scholar
• Scully R, Chen J, Ochs RL, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 1997;90(3):425–435. doi:10.1016/S0092-8674(00)80503-6
   PubMed Web of Science ®Google Scholar
• Tibbetts RS, Brumbaugh KM, Williams JM, et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 1999;13(2):152–157. doi:10.1101/gad.13.2.152
   PubMed Web of Science ®Google Scholar
• Tibbetts RS, Cortez D, Brumbaugh KM, et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 2000;14(23):2989–3002. doi:10.1101/gad.851000
   PubMed Web of Science ®Google Scholar
• Agarwal ML, Agarwal A, Taylor WR, et al. A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc Natl Acad Sci U S A. 1998;95(25):14775–14780. doi:10.1073/pnas.95.25.14775
   PubMed Web of Science ®Google Scholar
• Hastak K, Paul RK, Agarwal MK, et al. DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation. Proc Natl Acad Sci U S A. 2008;105(17):6314–6319. doi:10.1073/pnas.0802080105
   PubMed Web of Science ®Google Scholar
• Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 1998;282(5393):1497–1501. doi:10.1126/science.282.5393.1497
   PubMed Web of Science ®Google Scholar
• Gottifredi V, McKinney K, Poyurovsky MV, et al. Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block. J Biol Chem. 2004;279(7):5802–5810. doi:10.1074/jbc.M310373200
   PubMed Web of Science ®Google Scholar
• Autret A, Martin SJ. Bcl-2 family proteins and mitochondrial fission/fusion dynamics. Cell Mol Life Sci. 2010;67(10):1599–1606. doi:10.1007/s00018-010-0286-x
   PubMed Web of Science ®Google Scholar
• Estaquier J, Vallette F, Vayssiere JL, Mignotte B. The mitochondrial pathways of apoptosis. Adv Exp Med Biol. 2012;942:157–183.
   PubMed Web of Science ®Google Scholar
• Rello S, Stockert JC, Moreno V, et al. Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis. 2005;10(1):201–208. doi:10.1007/s10495-005-6075-6
   PubMed Web of Science ®Google Scholar
• Badrinath N, Yoo SY. Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy. Carcinogenesis. 2018;39(12):1419–1430. doi:10.1093/carcin/bgy148
   PubMed Web of Science ®Google Scholar
• Nguyen C, Pandey S. Exploiting mitochondrial vulnerabilities to trigger apoptosis selectively in cancer cells. Cancers (Basel). 2019;11(7).
   Web of Science ®Google Scholar
• Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166(3):555–566. doi:10.1016/j.cell.2016.07.002
   PubMed Web of Science ®Google Scholar
• Weinberg F, Hamanaka R, Wheaton WW, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A. 2010;107(19):8788–8793. doi:10.1073/pnas.1003428107
   PubMed Web of Science ®Google Scholar
• Sinha D, Duijf PHG, Khanna KK. Mitotic slippage: an old tale with a new twist. Cell Cycle. 2019;18(1):7–15. doi:10.1080/15384101.2018.1559557
   PubMed Web of Science ®Google Scholar
• Fotedar R, Flatt J, Gupta S, et al. Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. Mol Cell Biol. 1995;15(2):932–942. doi:10.1128/MCB.15.2.932
   PubMed Web of Science ®Google Scholar
• Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol. 1998;141(4):875–885. doi:10.1083/jcb.141.4.875
   PubMed Web of Science ®Google Scholar
• Porter LA, Cukier IH, Lee JM. Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis. Blood. 2003;101(5):1928–1933. doi:10.1182/blood-2002-04-1103
   PubMed Web of Science ®Google Scholar
• Yasuhira S, Shibazaki M, Nishiya M, et al. Paclitaxel-induced aberrant mitosis and mitotic slippage efficiently lead to proliferative death irrespective of canonical apoptosis and p53. Cell Cycle. 2016;15(23):3268–3277. doi:10.1080/15384101.2016.1242537
   PubMed Web of Science ®Google Scholar
• Yoshikawa R, Kusunoki M, Yanagi H, et al. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res. 2001;61(3):1029–1037.
   PubMed Web of Science ®Google Scholar
• Letai A, et al. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2002;2(3):183–192.
   PubMed Web of Science ®Google Scholar
• Pennington KL, Chan TY, Torres MP, et al. The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions. Oncogene. 2018;37(42):5587–5604. doi:10.1038/s41388-018-0348-3
   PubMed Web of Science ®Google Scholar
• Castedo M, Kroemer G. [Mitotic catastrophe: a special case of apoptosis]. J Soc Biol. 2004;198(2):97–103. French. doi:10.1051/jbio/2004198020097
   PubMedGoogle Scholar
• Castedo M, Perfettini J-L, Roumier T, et al. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene. 2004;23(25):4362–4370. doi:10.1038/sj.onc.1207572
   PubMed Web of Science ®Google Scholar
• Andreassen PR, Lohez OD, Lacroix FB, et al. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell. 2001;12(5):1315–1328. doi:10.1091/mbc.12.5.1315
   PubMed Web of Science ®Google Scholar
• Lanni JS, Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol. 1998;18(2):1055–1064. doi:10.1128/MCB.18.2.1055
   PubMed Web of Science ®Google Scholar
• Meek DW. The role of p53 in the response to mitotic spindle damage. Pathol Biol (Paris). 2000;48(3):246–254.
   PubMedGoogle Scholar
• Liu X, Zheng L, Zhang R, et al. Toxicological evaluation of advanced glycation end product Nε-(carboxymethyl)lysine: acute and subacute oral toxicity studies. Regul Toxicol Pharmacol. 2016;77:65–74. doi:10.1016/j.yrtph.2016.02.013
   PubMed Web of Science ®Google Scholar
• Siddique AB, King JA, Meyer SA, et al. Safety evaluations of single dose of the olive Secoiridoid S-(-)-oleocanthal in Swiss albino mice. Nutrients. 2020;12(2):314.
   PubMed Web of Science ®Google Scholar
• Vutukuri VR, Das MC, Reddy M, Prabodh S, Sunethri P. Evaluation of acute oral toxicity of ethanol leaves extract of Catharanthus roseus in Wistar Albino Rats. J Clin Diagn Res. 2017;11(3):Ff01–ff04.
   PubMedGoogle Scholar
• Worasuttayangkurn L, Nakareangrit W, Kwangjai J, et al. Acute oral toxicity evaluation of Andrographis paniculata-standardized first true leaf ethanolic extract. Toxicol Rep. 2019;6:426–430. doi:10.1016/j.toxrep.2019.05.003
   PubMed Web of Science ®Google Scholar